Greenville Health System ITOR - Cancer Institute

Greenville, South Carolina 29615

0 studies enrolling now · 1 studies all time

What they study most

Tumors With CDK4/6 Pathway Activation

Studies at this site

• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) — Completed